Abstract
Structure-activity relationship optimization on a series of phenylpyrazole amides led to the identification of a dual ROCK1 and ROCK2 inhibitor (25) which demonstrated good potency, kinome selectivity and favorable pharmacokinetic profiles. Compound 25 was selected as a tool molecule for in vivo studies including evaluating hemodynamic effects in telemeterized mice, from which moderate decreases in blood pressure were observed.
Keywords:
Dual inhibitor; Phenylpyrazole; ROCK; Rho kinase inhibitor; Telemetry study.
Copyright © 2020 Elsevier Ltd. All rights reserved.
MeSH terms
-
Amides / chemical synthesis
-
Amides / chemistry
-
Amides / pharmacology*
-
Animals
-
Blood Pressure / drug effects
-
Crystallography, X-Ray
-
Dose-Response Relationship, Drug
-
Drug Discovery*
-
Humans
-
Mice
-
Models, Molecular
-
Molecular Structure
-
Protein Kinase Inhibitors / chemical synthesis
-
Protein Kinase Inhibitors / chemistry
-
Protein Kinase Inhibitors / pharmacology*
-
Pyrazoles / chemical synthesis
-
Pyrazoles / chemistry
-
Pyrazoles / pharmacology*
-
Structure-Activity Relationship
-
rho-Associated Kinases / antagonists & inhibitors*
-
rho-Associated Kinases / metabolism
Substances
-
Amides
-
Protein Kinase Inhibitors
-
Pyrazoles
-
pyrazole
-
ROCK1 protein, human
-
ROCK2 protein, human
-
rho-Associated Kinases